Hrt Financial LP Curis Inc Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.47 - $17.22 $25,342 - $928,519	53,921 New	53,921 $29,000
Q2 2022 Aug 12, 2022	SELL	$0.71 - $2.43 $310,097 - $1.06 Million	-436,757 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.31 - $5.13 $1.01 Million - $2.24 Million	436,757 New	436,757 $1.04 Million
Q3 2020 Nov 13, 2020	SELL	$0.95 - $1.42 $17,715 - $26,480	-18,648 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.7 $11,748 - $31,701	18,648 New	18,648 $22,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $403M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.